Molecular structure of PKI (14-22) amide (myristoylated), CAS Number: 201422-03-9
PKI (14-22) amide (myristoylated) (CAS 201422-03-9)
See product citations (2)
Application:
PKI (14-22) amide (myristoylated) is a useful heat stable cAMP-dependent protein kinase inhibitor
CAS Number:
201422-03-9
Molecular Weight:
1209.5
Molecular Formula:
C53H100N20O12
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Product Citations
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
PKI (14-22) amide (myristoylated) is a modified version of vasoactive intestinal peptide (VIP), a peptide hormone found naturally in the body. PKI (14-22) amide (myristoylated) is a useful heat stable PKA (cAMP-dependent protein kinase) inhibitor. This is often used to study PKA in cellular systems in-vitro. PKI (14-22) amide (myristoylated) consists of a 14-amino acid sequence with a myristoylated N-terminal amide, which enhances its stability, bioavailability, and effectiveness.
PKI (14-22) amide (myristoylated) (CAS 201422-03-9) References
- Physiological patterns of electrical stimulation can induce neuronal gene expression by activating N-type calcium channels. | Brosenitsch, TA. and Katz, DM. 2001. J Neurosci. 21: 2571-9. PMID: 11306610
- Corticotropin-releasing factor and urocortin I activate CREB through functionally selective Gβγ signaling in hippocampal pyramidal neurons. | Stern, CM., et al. 2011. Eur J Neurosci. 34: 671-81. PMID: 21819464
- An unsuspected property of natriuretic peptides: promotion of calcium-dependent catecholamine release via protein kinase G-mediated phosphodiesterase type 3 inhibition. | Chan, NY., et al. 2012. Circulation. 125: 298-307. PMID: 22158783
- cAMP protects acute promyelocytic leukemia cells from arsenic trioxide-induced caspase-3 activation and apoptosis. | Safa, M., et al. 2014. Eur J Pharmacol. 736: 115-23. PMID: 24815320
- β1-adrenergic receptor activation enhances memory in Alzheimer's disease model. | Coutellier, L., et al. 2014. Ann Clin Transl Neurol. 1: 348-360. PMID: 24883337
- G protein-coupled estrogen receptor 1 mediates relaxation of coronary arteries via cAMP/PKA-dependent activation of MLCP. | Yu, X., et al. 2014. Am J Physiol Endocrinol Metab. 307: E398-407. PMID: 25005496
- Cannabinoid signalling inhibits sarcoplasmic Ca2+ release and regulates excitation-contraction coupling in mammalian skeletal muscle. | Oláh, T., et al. 2016. J Physiol. 594: 7381-7398. PMID: 27641745
- Endogenous Gαq-Coupled Neuromodulator Receptors Activate Protein Kinase A. | Chen, Y., et al. 2017. Neuron. 96: 1070-1083.e5. PMID: 29154125
- Combination therapy with protein kinase inhibitor H89 and Tetrandrine elicits enhanced synergistic antitumor efficacy. | Yu, M., et al. 2018. J Exp Clin Cancer Res. 37: 114. PMID: 29866132
- Vasoactive intestinal peptide controls the suprachiasmatic circadian clock network via ERK1/2 and DUSP4 signalling. | Hamnett, R., et al. 2019. Nat Commun. 10: 542. PMID: 30710088
- Protein Phosphatase 1 Inhibitor-1 Mediates the cAMP-Dependent Stimulation of the Renal NaCl Cotransporter. | Penton, D., et al. 2019. J Am Soc Nephrol. 30: 737-750. PMID: 30902838
- Dopaminergic Transmission Rapidly and Persistently Enhances Excitability of D1 Receptor-Expressing Striatal Projection Neurons. | Lahiri, AK. and Bevan, MD. 2020. Neuron. 106: 277-290.e6. PMID: 32075716
- Inhibitors of protein kinases A and C impair the motility of oncospheres of the model tapeworm Hymenolepis microstoma. | Preza, M., et al. 2021. Mol Biochem Parasitol. 246: 111423. PMID: 34562553
Inhibitor of:
AKAP 100, AKAP 14, AKAP 149_AKAP 121, AKAP 150, AKAP 2, AKAP 220, AKAP 3, AKAP 82, cAMP-GEFII, Cdc35, PALM2-AKAP2, PKA, PKA Iα reg, PKA IIα reg, PKAα cat, and PKAβ cat.Activator of:
AKAP 10, and AKIP.Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
PKI (14-22) amide (myristoylated), 0.5 mg | sc-471154 | 0.5 mg | $135.00 |